Inspiremd Stock Buy Hold or Sell Recommendation
| NSPR Stock | USD 2.87 0.06 2.14% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding InspireMD is 'Strong Hold'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell InspireMD within the specified time frame.
Check out InspireMD Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide. Note, we conduct extensive research on individual companies such as InspireMD and provide practical buy, sell, or hold advice based on investors' constraints. InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
InspireMD |
Execute InspireMD Buy or Sell Advice
The InspireMD recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on InspireMD. Macroaxis does not own or have any residual interests in InspireMD or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute InspireMD's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
InspireMD Trading Alerts and Improvement Suggestions
| InspireMD had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 7.01 M. Net Loss for the year was (32.01 M) with profit before overhead, payroll, taxes, and interest of 1.54 M. | |
| InspireMD currently holds about 26.47 M in cash with (21.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| InspireMD has a poor financial position based on the latest SEC disclosures | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: InspireMD, Inc. Reports Q4 Loss, Tops Revenue Estimates |
InspireMD Returns Distribution Density
The distribution of InspireMD's historical returns is an attempt to chart the uncertainty of InspireMD's future price movements. The chart of the probability distribution of InspireMD daily returns describes the distribution of returns around its average expected value. We use InspireMD price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of InspireMD returns is essential to provide solid investment advice for InspireMD.
| Mean Return | 0.08 | Value At Risk | -6.12 | Potential Upside | 7.97 | Standard Deviation | 4.22 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of InspireMD historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
InspireMD Stock Institutional Investors
The InspireMD's institutional investors refer to entities that pool money to purchase InspireMD's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Essex Investment Management Company, Llc | 2024-12-31 | 72.6 K | Northern Trust Corp | 2024-12-31 | 48 K | Schonfeld Strategic Advisors Llc | 2024-12-31 | 30.1 K | Elias Asset Management Inc | 2024-12-31 | 30 K | Mesirow Fin Investmt Mgmt Intl Equity | 2024-12-31 | 30 K | Hollencrest Securities, Llc | 2024-12-31 | 20 K | Geode Capital Management, Llc | 2024-12-31 | 18.2 K | Legato Capital Management Llc | 2024-12-31 | 17.7 K | Avestar Capital, Llc | 2024-12-31 | 15 K | Rosalind Advisors, Inc. | 2024-12-31 | 2.5 M | Orbimed Advisors, Llc | 2024-12-31 | 2.1 M |
InspireMD Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 7.1M | (641K) | (7.4M) | 5.0M | 9.3M | 9.7M | |
| Free Cash Flow | (9.2M) | (13.6M) | (16.0M) | (16.8M) | (23.3M) | (22.1M) | |
| Capital Expenditures | 88K | 344K | 473K | 381K | 1.4M | 1.5M | |
| Net Income | (10.5M) | (14.9M) | (18.5M) | (19.9M) | (32.0M) | (30.4M) | |
| End Period Cash Flow | 12.6M | 12.0M | 4.6M | 9.6M | 18.9M | 19.9M | |
| Change To Inventory | (179K) | 272K | (478K) | (485K) | (464K) | (440.8K) | |
| Depreciation | 151K | 161K | 188K | 232K | 280K | 198.1K | |
| Other Non Cash Items | (4K) | (28K) | 14K | (381K) | (281K) | (267.0K) | |
| Investments | (187K) | (22M) | 8.4M | (16.1M) | (14.5M) | (13.8M) |
InspireMD Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to InspireMD or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that InspireMD's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a InspireMD stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.16 | |
β | Beta against Dow Jones | 0.67 | |
σ | Overall volatility | 4.32 | |
Ir | Information ratio | 0.05 |
InspireMD Volatility Alert
InspireMD shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure InspireMD's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact InspireMD's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.InspireMD Fundamentals Vs Peers
Comparing InspireMD's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze InspireMD's direct or indirect competition across all of the common fundamentals between InspireMD and the related equities. This way, we can detect undervalued stocks with similar characteristics as InspireMD or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of InspireMD's fundamental indicators could also be used in its relative valuation, which is a method of valuing InspireMD by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare InspireMD to competition |
| Fundamentals | InspireMD | Peer Average |
| Return On Equity | -0.67 | -0.31 |
| Return On Asset | -0.37 | -0.14 |
| Operating Margin | (4.68) % | (5.51) % |
| Current Valuation | 33.6 M | 16.62 B |
| Shares Outstanding | 26.08 M | 571.82 M |
| Shares Owned By Insiders | 20.74 % | 10.09 % |
| Shares Owned By Institutions | 48.73 % | 39.21 % |
| Number Of Shares Shorted | 199.09 K | 4.71 M |
| Price To Earning | (0.16) X | 28.72 X |
| Price To Book | 1.76 X | 9.51 X |
| Price To Sales | 10.75 X | 11.42 X |
| Revenue | 7.01 M | 9.43 B |
| Gross Profit | 1.54 M | 27.38 B |
| EBITDA | (33.5 M) | 3.9 B |
| Net Income | (32.01 M) | 570.98 M |
| Cash And Equivalents | 26.47 M | 2.7 B |
| Cash Per Share | 3.18 X | 5.01 X |
| Total Debt | 1.8 M | 5.32 B |
| Debt To Equity | 0.07 % | 48.70 % |
| Current Ratio | 6.26 X | 2.16 X |
| Book Value Per Share | 1.61 X | 1.93 K |
| Cash Flow From Operations | (21.87 M) | 971.22 M |
| Short Ratio | 3.23 X | 4.00 X |
| Earnings Per Share | (0.71) X | 3.12 X |
| Target Price | 4.75 | |
| Number Of Employees | 80 | 18.84 K |
| Beta | 0.88 | -0.15 |
| Market Capitalization | 73.3 M | 19.03 B |
| Total Asset | 46.81 M | 29.47 B |
| Retained Earnings | (253.51 M) | 9.33 B |
| Working Capital | 38.14 M | 1.48 B |
| Current Asset | 4.63 M | 9.34 B |
| Current Liabilities | 6.83 M | 7.9 B |
Note: Acquisition by Roubin Gary S of 11098 shares of InspireMD at 3.14 subject to Rule 16b-3 [view details]
InspireMD Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as InspireMD . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 4607.01 | |||
| Daily Balance Of Power | 0.3333 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 2.81 | |||
| Day Typical Price | 2.83 | |||
| Price Action Indicator | 0.09 | |||
| Period Momentum Indicator | 0.06 |
About InspireMD Buy or Sell Advice
When is the right time to buy or sell InspireMD? Buying financial instruments such as InspireMD Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having InspireMD in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Medical Equipment Thematic Idea Now
Medical Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Medical Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Medical Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.